Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
The facility is expected to become operational by FY2028-29
Ivermectin Tablets USP, 3 mg, are prescription anti-parasitic medications primarily indicated for treating parasitic worm infections in humans
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
Brivaracetam Oral Solution (10 mg/mL) is a prescription antiepileptic drug (anticonvulsant) used for treatment of partial-onset seizures in patients 1 month of age and older
New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform
Investment marks continued progress against AbbVie's $100 billion commitment to U.S. R&D and capital investments, including manufacturing, over the next decade
If approved, DTX401 would be the first treatment to address the disease at its root cause
The project entails a total planned capital expenditure of approximately Rs. 500 - 520 crore
Subscribe To Our Newsletter & Stay Updated
